Suppr超能文献

肝硬化患者肝移植中 DNA 指数的预后意义。

Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis.

机构信息

Department of General, Visceral, and Transplantation Surgery, Charite' Campus Virchow-Klinikum, University Medicine Berlin, Berlin, Germany.

出版信息

Ann Surg. 2009 Dec;250(6):1008-13. doi: 10.1097/sla.0b013e3181b2b195.

Abstract

OBJECTIVE

This study was conducted to evaluate the prognostic significance of the tumor DNA index in patients receiving liver transplantation for hepatocellular carcinoma (HCC) in cirrhosis.

BACKGROUND

In patients suffering from HCC in cirrhosis, the current selection for liver transplantation does not optimally achieve the goal to simultaneously maximize the number of viable transplant candidates and reject the smallest number of those who could have benefited. This is the first report on the prognostic significance of the tumor DNA index.

PATIENTS AND METHODS

From 1988 to 2007, liver transplantation for HCC in cirrhosis was performed in 246 consecutive patients. The DNA-index was determined by Feulgen staining and semiautomatical image analysis. Interpretation of DNA histograms followed the recommendations outlined in the European Society for Analytical Cellular Pathology consensus report on diagnostic DNA image cytometry.

RESULTS

A DNA-index <or=1.5 was detected in the HCC of 159 patients (65%). Five- and 10-year post-transplant survival rates in this group were 86% and 80%, respectively. The DNA-index exceeded 1.5 in 87 patients (35%). These patients had 5- and 10-year survival rates of 27% and 6%, respectively, which were significantly lower than in the DNA-index <or=1.5 group (P < 0.0001). On univariate analysis, DNA-index, vascular invasion, fulfillment of the Milan criteria, and histopathological grading were prognostic parameters. In the multivariate analysis, only DNA-index (odds ratio: 11.9; 95% confidence interval: 7.1-20.0; P < 0.0001) and vascular infiltration (odds ratio: 1.7; 95% confidence interval: 1.1-2.6; P < 0.01) were identified as prognostic variables.

CONCLUSION

This is the first study to describe the DNA-index as a strong prognostic indicator after liver transplantation for HCC in cirrhosis. At this time, determination of the DNA-index is likely to be the most promising diagnostic tool in the selection of transplant candidates.

摘要

目的

本研究旨在评估肿瘤 DNA 指数在肝硬化患者接受肝移植治疗肝细胞癌(HCC)中的预后意义。

背景

在患有肝硬化 HCC 的患者中,目前的肝移植选择并未最佳地实现同时最大化有活力的移植候选人数并拒绝最小数量可能受益的人的目标。这是关于肿瘤 DNA 指数预后意义的首次报道。

患者和方法

从 1988 年到 2007 年,对 246 例连续肝硬化 HCC 患者进行了肝移植。通过 Feulgen 染色和半自动图像分析确定 DNA 指数。DNA 直方图的解释遵循欧洲分析细胞病理学协会关于诊断 DNA 图像细胞术的共识报告中概述的建议。

结果

在 159 例患者(65%)的 HCC 中检测到 DNA 指数<or=1.5。该组的 5 年和 10 年移植后生存率分别为 86%和 80%。在 87 例患者(35%)中,DNA 指数超过 1.5。这些患者的 5 年和 10 年生存率分别为 27%和 6%,明显低于 DNA 指数<or=1.5 组(P<0.0001)。在单因素分析中,DNA 指数、血管侵犯、符合米兰标准和组织病理学分级是预后参数。在多因素分析中,只有 DNA 指数(优势比:11.9;95%置信区间:7.1-20.0;P<0.0001)和血管浸润(优势比:1.7;95%置信区间:1.1-2.6;P<0.01)被确定为预后变量。

结论

这是第一项描述 DNA 指数作为肝硬化患者 HCC 肝移植后强烈预后指标的研究。目前,确定 DNA 指数可能是选择移植候选者的最有前途的诊断工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验